Status:
TERMINATED
N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary Hypertension
Lead Sponsor:
Christiana Care Health Services
Collaborating Sponsors:
Thomas Jefferson University
Conditions:
Persistent Pulmonary Hypertension of Newborn
Eligibility:
All Genders
Up to 6 years
Brief Summary
Babies who are suspected of having persistent pulmonary hypertension (PPHN) will be included in this study. PPHN is a condition in which the blood is restricted from flowing to the lungs in a normal w...
Detailed Description
PPHN occurs in infant \> or = 34 weeks gestation and is characterized by an elevation in pulmonary vascular resistance (PVR) and right-to-left shunting of the blood at the atrial, ductal, and pulmonar...
Eligibility Criteria
Inclusion
- \>/= 34 weeks gestation at birth
- clinical diagnosis of PPHN
Exclusion
- newborns with evidence of structural heart disease, congenital anomalies and prior use of inhaled nitric oxide.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00443859
Start Date
February 1 2007
End Date
September 1 2008
Last Update
July 11 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Christiana Hospital
Newark, Delaware, United States, 19718
2
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107